Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.620
+0.200 (14.08%)
At close: Mar 4, 2026, 4:00 PM EST
1.649
+0.029 (1.78%)
After-hours: Mar 4, 2026, 7:55 PM EST

Health In Tech Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Health In Tech stock has a target of 2.50, which predicts an increase of 54.32% from the current stock price of 1.62.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $2.50 $2.50 $2.50 $2.50
Change +54.32% +54.32% +54.32% +54.32%
* Price targets were last updated on Jun 26, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Health In Tech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '26Feb '26
Strong Buy 11
Buy 00
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Initiates
$2.5
Strong Buy Initiates $2.5 +54.32% Jun 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
32.70M
from 19.49M
Increased by 67.75%
Revenue Next Year
42.46M
from 32.70M
Increased by 29.85%
EPS This Year
0.02
from 0.01
Increased by 51.50%
EPS Next Year
-0.01
from 0.02
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
5.77M19.15M19.49M32.70M42.46M80.91M
Revenue Growth
-231.93%1.77%67.75%29.85%90.58%
EPS
0.000.050.010.02-0.010.19
EPS Growth
-2,788.89%-79.10%51.50%--
Forward PE
---106.93-8.44
No. Analysts ---332
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 34.8M 45.3M
Avg 32.7M 42.5M
Low 31.0M 40.1M

Revenue Growth

Revenue Growth 202520262027
High
78.5%
38.5%
Avg
67.8%
29.9%
Low
58.9%
22.7%

EPS Forecast

EPS 202520262027
High 0.02 -
Avg 0.02 -0.01
Low 0.01 -0.01

EPS Growth

EPS Growth 202520262027
High
110.0%
-
Avg
51.5%
-
Low
-2.0%
-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.